Panobinostat (LBH589) is an HDAC (histone deactylase) inhibitor of research interest for multiple diseases such as multiple myeloma. Panobinostat was reported to inhibit several human multiple myeloma cell lines with and IC50 ≥ 20nM. Panobinostat was also reported to induce expression of DNA damage response genes and induce apoptosis in Ph- acute lymphoblastic leukemia cells. Panobinostat has potential applications in several different forms of cancer, in addition to spinal muscular atrophy and HIV therapy.
1. Catley, L., et al. 2006. Blood. 108: 3441-3449. PMID: 16728695
2. Fiskus, W., et al. 2006. Mol. Cancer Ther. 5: 3096-3104. PMID: 17172412
3. Scuto, A., et al. 2008. Blood. 111: 5093-5100. PMID: 18349321
4. Sasaki, D., et al. 2011. Haematologica. PMID: 21228036. PMID: 21228036
다른 사용자의 Panobinostat (CAS 404950-80-7)사용법보기. 클릭하여 PubMed entry보기 .
PMID: # 30515817 Liao, W. et al. 2019. J. Cell. Physiol. 234: 12646-12662.
PMID: # 31054975 Ali, I.|Ruiz, DG.|Ni, Z.|Johnson, JR.|Zhang, H.|Li, PC.|Khalid, MM.|Conrad, RJ.|Guo, X.|Min, J.|Greenblatt, J.|Jacobson, M.|Krogan, NJ.|Ott, M.| et al. 2019. Mol. Cell. 74: 1164-1174.e4.
PMID: # 29778644 Hepp, MI. et al. 2018. Biochim. Biophys. Acta.
PMID: # 26379230 Franken, H. et al. 2015. Nat Protoc. 10: 1567-93.
PMID: # 32365976 Cancers (Basel). 12:
산타크루즈바이오테크놀러지는 생물의학연구에 필요한 제품을 개발하는 선구자입니다. Toll Free 1-800-457-3801로 연락주세요. Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. 판권소유. "Santa Cruz Biotechnology", 와 Santa Cruz Biotechnology, Inc. 로고, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", 및 San Juan Ranch 로고, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz"와 "EZ Touch" 는 Santa Cruz Biotechnology, Inc의 등록된 상표입니다. 모든 상표는 각자 소유주의 소유입니다.